Chronic Myeloproliferative Disorders Unknown Status Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00589602T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other DiseasesTreatment
NCT00691015Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantSupportive Care